Up-regulation of both EF-Tu and the cytoplasmic elongation factor EF-1a in human pancreatic adenocarcinoma has been reported [10,11], whereas absence of EF-Tu expression in human hepatocellular carcinoma cell lines HepG2 was also observed [12]. The gene discussed is TUFM; the disease is pancreatic adenocarcinoma.